A61K 31/357
Having two or more oxygen atoms in the same ring
Official title: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
A61K31/357 (Having two or more oxygen atoms in the same ring) appears on 1,406 US grants and 2,537 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,406
- Published applications
- 2,537
- Assignees
- 1,185
- Inventors
- 5,317
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 6 | 0 |
| 1997 | 9 | 0 |
| 1998 | 10 | 0 |
| 1999 | 17 | 0 |
| 2000 | 16 | 0 |
| 2001 | 20 | 7 |
| 2002 | 17 | 32 |
| 2003 | 12 | 27 |
| 2004 | 11 | 52 |
| 2005 | 10 | 35 |
| 2006 | 18 | 48 |
| 2007 | 5 | 39 |
| 2008 | 12 | 50 |
| 2009 | 19 | 62 |
| 2010 | 29 | 73 |
| 2011 | 22 | 79 |
| 2012 | 37 | 78 |
| 2013 | 47 | 106 |
| 2014 | 75 | 130 |
| 2015 | 78 | 150 |
| 2016 | 86 | 131 |
| 2017 | 96 | 136 |
| 2018 | 89 | 117 |
| 2019 | 96 | 151 |
| 2020 | 95 | 151 |
| 2021 | 85 | 163 |
| 2022 | 77 | 135 |
| 2023 | 70 | 157 |
| 2024 | 90 | 151 |
| 2025 | 77 | 160 |
| 2026 | 42 | 117 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Mutant NGAL proteins and uses thereof29 Sep 2026US 12,746,270 B2The Trustees of Columbia University in the City of New York
- Methods of treating Lennox-Gastaut Syndrome using fenfluramine15 Sep 2026US 12,734,137 B2Zogenix International Limited
- Method for treating diabetes by using Antrodia camphorata compound15 Sep 2026US 12,734,148 B2Lantyng Biotechnology Corp.
- Taxane analogs for the treatment of brain cancer15 Sep 2026US 12,734,149 B2Tapestry Pharmaceuticals, Inc.
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Conformationally restricted phenethylamine analogs8 Oct 2026US 2026/0308109 A1
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Ingestible formulations comprising methylliberine and one or more sugars and their use to treat the adverse effects of alcohol consumption1 Oct 2026US 2026/0294917 A1Lucid Psycheceuticals Inc.
- Compositions and method for management of pain and allergy24 Sep 2026US 2026/0284003 A1
- Dual inhibitors of dyrk1a and 5-ht2 for treating a brain disorder24 Sep 2026US 2026/0284018 A1
Most cited
By later US patents
- Styryl compounds which inhibit EGF receptor protein tyrosine kinase181US 5,217,999 AYissum Research Development Company of the Hebrew University of Jerusalem · 1993
- Compositions and methods for treating surgical adhesions160US 6,689,803 B2Angiotech Pharmaceuticals, Inc. · 2004
- Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors129US 5,466,861 ALa Jolla Cancer Research Foundation · 1995
- Modulators of ATP-binding cassette transporters117US 7,691,902 B2Vertex Pharmaceuticals Incorporated · 2010
- Use of sulfamate derivatives for treating impulse control disorders114US 6,323,236 B2University of Cincinnati · 2001